Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 4, 2000, Pages 439-443

  Pearce, Callum B ^a   Duncan, Hamish D ^a   Timmis, Lynne ^b   Green, Jonathan R B ^b  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; Helicobacter pylori; Inflammatory bowel diseases; Seroprevalence; Ulcerative colitis

Indexed keywords

CARBON 13; MESALAZINE; SALAZOSULFAPYRIDINE; UREA;

ADOLESCENT; ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE BIOPSY; IRRITABLE COLON; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIODIAGNOSIS; ULCERATIVE COLITIS;

EID: 0033994863     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012040-00012     Document Type: Article

References (20)

1. 1 Fung WP, Papadimitriou JM, Matz LR. Endoscopic, histological and ultrastructural correlations in chronic gastritis. Am J Gastroenterol 1979; 71:269-279.
2. 2 Marshall B, Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i:1273-1274.
3. 3 Borody TJ, George LL, Brandl S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroentetol 1991; 86:1154-1157.
4. 4 Eurogast Study Group, An international association between Helicobacter pylori and gastric carcinoma. Lancet 1993; 341:1359-1362.
5. 5 Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of H. pylori in patients with Barrett's oesophagus. Am J Gastroenterol 1992; 87:1598-1600.
6. 6 Murray LJ, Bamford KB, O'Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease and social class. Br Heart J 1995; 74:497-501.
7. 7 Dooley CP. Helicobacter infection and peptic ulcer disease. Curr Opin Gastroenterol 1993; 9:112-117.
8. 8 El-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, McColl KE. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 1994; 35:1385-1388.
9. 9 Halme L, Rautelin H, Leidenius M, Kosunen TU. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol 1996; 49:65-67.
10. 10 Wagtmans MJ, Witte AMC, Taylor DR, Biemond I, Veenendaal RA, Verspaget HW, et al. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol 1997; 32:712-718.
11. 11 Parente F, Molteni P, Bollani S, Maconi G, Vago L, Duca PG, et al. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. Scand J Gastroenterol 1997; 32:1140-1146.
12. 12 Graham DY, Malary HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 1991; 100:1495-1501.
13. 13 Gommer SS, Jasin HE. In vitro immunomodulatory effects of sulphasalazine and its metabolites. J Rheumatol 1988; 15:580-586.
14. 14 Gibson RP, Jewell DP. Sulphasalazine and its derivatives, natural killer activity and ulcerative colitis. Clin Sci 1985; 69:177-184.
15. 15 Halme L, Karkkainen P, Rautelin H, Kosunen TU, Sipponen P, High frequency of Helicobacter negative gastritis in patients with Crohn's disease. Gut 1996; 38:379-383.
16. 16 Taha AS, Russell RI. Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut 1993; 34:580-583.
17. 17 Sorensen VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with Crohn's disease. Gut 1987; 28:382-385.
18. 18 Manousos ON, Triantaphyllidis I, Emmanouilidis A, Papademitriou C. Ulcerative colitis in Greece. Epidemiologic and clinical data. Scand J Gastroenterol Suppl 1989; 170:25-26.
19. 19 Samuelsson SM, Ekbom A, Zack M, Helmick CG, Adami HO. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut 1991; 32:1526-1530.
20. 20 Taha AS, Sturrock RD, Russell RI. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulphasalazine and NSAIDs. Am J Gastroenterol 1992; 87:1732-1735.